Metabolomics

Dataset Information

0

Analysis of the effects of Tyrosine Kinase Inhibitors Sunitinib and Erlotinib on Liver Metabolism In Vivo

ABSTRACT:

ORGANISM(S): Mus Musculus

TISSUE(S): Liver

DISEASE(S): Cancer

PROVIDER: ST000894 | MetabolomicsWorkbench |

REPOSITORIES: MetabolomicsWorkbench

Json Xml

Dataset's files

Source:
Action DRS
mwtab Other
Items per page:
1 - 1 of 1

Similar Datasets

Unknown Non-Targeted Metabolomics Analysis of the Effects of Tyrosine Kinase Inhibitors Sunitinib and Erlotinib on Heart, Muscle, Liver and Serum Metabolism In Vivo.
| S-EPMC5618316 | biostudies-literature
Metabolomics Analysis of the effects of Tyrosine Kinase Inhibitors Sunitinib and Erlotinib on Muscle Metabolism In Vivo
| ST000896 | MetabolomicsWorkbench
Metabolomics Analysis of the effects of Tyrosine Kinase Inhibitors Sunitinib and Erlotinib on Heart, Metabolism In Vivo
| ST000893 | MetabolomicsWorkbench
Metabolomics Analysis of the effects of Tyrosine Kinase Inhibitors Sunitinib and Erlotinib on Serum Metabolism In Vivo using Non-Targeted Metabolomics Analysis
| ST000895 | MetabolomicsWorkbench
Unknown URI alleviates tyrosine kinase inhibitors-induced ferroptosis by reprogramming lipid metabolism in p53 wild-type liver cancers.
| S-EPMC10560259 | biostudies-literature
Unknown Inhibition of OATP1B1 by tyrosine kinase inhibitors: in vitro-in vivo correlations.
| S-EPMC3929889 | biostudies-literature
Unknown Effects of the kinase inhibitor sorafenib on heart, muscle, liver and plasma metabolism in vivo using non-targeted metabolomics analysis.
| S-EPMC5727336 | biostudies-literature
Unknown Autophagy inhibition improves the cytotoxic effects of receptor tyrosine kinase inhibitors.
| S-EPMC5916832 | biostudies-literature
Unknown Protein and metabolic profiles of tyrosine kinase inhibitors co-resistant liver cancer cells.
| S-EPMC11149701 | biostudies-literature
Unknown Nanomedicine of tyrosine kinase inhibitors.
| S-EPMC7778595 | biostudies-literature